BI Asset Management Fondsmaeglerselskab’s Pacira BioSciences PCRX Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,799	Closed	-$196K	–	782
2023 Q1	$196K	Sell	4,799 -159	-3%	-$6.33K	0.01%	589
2022 Q4	$191K	Buy	+4,958	New	+$241K	0.01%	531

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's PCRX Position: Q2 2023 in Review

BI Asset Management Fondsmaeglerselskab sold out of Pacira BioSciences (PCRX) in Q2 2023, closing a stake of 4,799 shares — an estimated $196K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in PCRX in Q4 2022 and held it in 2 quarters. The position peaked at $196K in Q1 2023. 258 funds tracked by Wall St. Rank hold PCRX as of Q2 2023.

BI Asset Management Fondsmaeglerselskab reported no remaining Pacira BioSciences position as of Q2 2023 after selling out during the quarter.
BI Asset Management Fondsmaeglerselskab sold 4,799 Pacira BioSciences shares in Q2 2023, an estimated $196K.
BI Asset Management Fondsmaeglerselskab first reported a position in Pacira BioSciences in Q4 2022 and held it in 2 quarters.
BI Asset Management Fondsmaeglerselskab's Pacira BioSciences position peaked at $196K in Q1 2023.
258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2023.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2023, filed 3 Aug 2023.